IDL Biotech AB genomför nyemission för att finansiera en offensiv tillväxtstrategi
Information & Documents
Issuer:
IDL Biotech AB
Chairman:
Hans Öhrström
CEO:
Charlotte Berg
Subscription period:
2018-11-12 - 2018-11-26
Issue size:
SEK 39m
Subscription price:
SEK 1.2 per share
Emissionsvolym:
Cirka 39,4 MSEK
Teckningskurs:
1,20 SEK
Antal erbjudna aktier:
32 805 822
Värdering pre-money:
Cirka 33 MSEK
Teckningsförbindelser:
80%
Garantiåtaganden:
20%
Get notified
Do you want to get email notifications about upcoming transactions? Let us know at emissioner@redeye.se
Access our tools & Data
Get your hands on the same professional tools and data that our analyst team use for creating the best return on investment. Sign up for our Premium and access it all today:
All our tools and data included
From 349 SEK / Month Cancel any time